Literature DB >> 190272

The lipoprotein abnormality in Tangier disease: quantitation of A apoproteins.

G Assmann, E Smootz, K Adler, A Capurso, K Oette.   

Abstract

In this study we have determined by radioimmunoassay and double immunoelectrophoresis the total quantities and distributions of A apoproteins in three adult patients affected with Tangier disease (hereditary alpha-lipoprotein deficiency). Compared with normal plasma, the total quantities of apoproteins A-I and A-II in Tangier plasma were determined to be less than 1% and 5-7%, respectively. In Tangier patients, approximately 90% of the apoprotein A-I sedimented when ultracentrifugations of plasma were carried out at density 1.21 g/ml KBr. By contrast, more than 95% of the apoprotein A-II floated under those conditions. In normal plasma, approximately 90% of both apoproteins A-I and A-II is found in the 1.063-1.21-g/ml KBr density fraction. These findings suggest that complete dissociation of A apoproteins occurs in Tangier plasma. This dissociation of apoproteins was confirmed by double immunoelectrophoresis with monospecific antisera. Immunochemical and electrophoretic experiments did not provide evidence for a structural abnormality of apoprotein A-I in these patients, The results taken together strongly suggest that normal high-density lipoproteins are absent from Tangier plasma.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 190272      PMCID: PMC333394          DOI: 10.1172/JCI108672

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

1.  HETEROGENEITY OF PLASMA HIGH DENSITY LIPOPROTEINS.

Authors:  R I LEVY; D S FREDRICKSON
Journal:  J Clin Invest       Date:  1965-03       Impact factor: 14.808

2.  The pathology of Tangier disease. A light and electron microscopic study.

Authors:  V J Ferrans; D S Fredrickson
Journal:  Am J Pathol       Date:  1975-01       Impact factor: 4.307

3.  Measurement of human high density lipoprotein apolipoprotein A-1 in serum by radioimmunoassay.

Authors:  J B Karlin; D J Juhn; J I Starr; A M Scanu; A H Rubenstein
Journal:  J Lipid Res       Date:  1976-01       Impact factor: 5.922

4.  Radioimmunoassay of human high density lipoprotein apo-protein A-1.

Authors:  M Fainaru; M C Glangeaud; S Eisenberg
Journal:  Biochim Biophys Acta       Date:  1975-04-29

5.  Effect of the human plasma apolipoproteins and phosphatidylcholine acyl donor on the activity of lecithin: cholesterol acyltransferase.

Authors:  A K Soutar; C W Garner; H N Baker; J T Sparrow; R L Jackson; A M Gotto; L C Smith
Journal:  Biochemistry       Date:  1975-07-15       Impact factor: 3.162

6.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

7.  Electroimmuno assay.

Authors:  C B Laurell
Journal:  Scand J Clin Lab Invest Suppl       Date:  1972

8.  Quantitation of apolipoprotein A-I of human plasma high density lipoprotein.

Authors:  J J Albers; P W Wahl; V G Cabana; W R Hazzard; J J Hoover
Journal:  Metabolism       Date:  1976-06       Impact factor: 8.694

9.  Determination of apolipoprotein A and its constitutive A-I and A-II polypeptides by separate electroimmunoassays.

Authors:  M D Curry; P Alaupovic; C A Suenram
Journal:  Clin Chem       Date:  1976-03       Impact factor: 8.327

10.  The structure of human high density lipoprotein and the levels of apolipoprotein A-I in plasma as determined by radioimmunoassay.

Authors:  G Schonfeld; B Pfleger
Journal:  J Clin Invest       Date:  1974-08       Impact factor: 14.808

View more
  18 in total

Review 1.  Emerging roles of the intestine in control of cholesterol metabolism.

Authors:  Janine-K Kruit; Albert K Groen; Theo J van Berkel; Folkert Kuipers
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

2.  Isolation and characterization of an abnormal high density lipoprotein in Tangier Diesase.

Authors:  G Assmann; P N Herbert; D S Fredrickson; T Forte
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

3.  Characterization of high density lipoproteins in patients heterozygous for Tangier disease.

Authors:  G Assmann; O Simantke; H E Schaefer; E Smootz
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

4.  [Tangier-disease (author's transl)].

Authors:  G Assmann
Journal:  Klin Wochenschr       Date:  1979-01-15

5.  [Apolipoproteinopathies].

Authors:  G Assmann
Journal:  Klin Wochenschr       Date:  1983-02-15

6.  Tangier disease: heterozygote detection and linkage analysis.

Authors:  B K Suarez; G Schonfeld; R S Sparkes
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

Review 7.  [HDL cholesterol: biochemical aspects (author's transl)].

Authors:  G Assmann; H Schriewer
Journal:  Klin Wochenschr       Date:  1980-08-01

8.  Tangier disease: defective recombination of a specific Tangier apolipoprotein A-I isoform (pro-apo A-i) with high density lipoproteins.

Authors:  G Schmitz; G Assmann; S C Rall; R W Mahley
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

9.  Characterization of apolipoprotein A-I- and A-II-containing lipoproteins in a new case of high density lipoprotein deficiency resembling Tangier disease and their effects on intracellular cholesterol efflux.

Authors:  M C Cheung; A J Mendez; A C Wolf; R H Knopp
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

10.  A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family.

Authors:  G Franceschini; C R Sirtori; A Capurso; K H Weisgraber; R W Mahley
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.